Lymphoproliferative disease and cancer among patients with common variable immunodeficiency. Issue 4 (April 2015)

• Record Type: Journal Article
• Authors: Gangemi, S.; Allegra, A.; Musolino, C.
• Is Part Of: Leukemia research. Volume 39:Issue 4(2015:Apr.)
• Page Start: 389
• Page End: 396
• Publication Date: 2015-04
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2015.02.002
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Common variable immunodeficiency (CVI) is the commonest primary antibody disorder.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">A higher frequency of malignancy, especially lymphoma, has been reported.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">The reasons for the increased susceptibility to lymphoid malignancies are unclear.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">This review discusses the latest insights into the links CVI and malignancies.</p> </list-item> </list> </p> </sec> </abstract>